Amicus Therapeutics, Inc.
FOLD
$6.83
$0.131.94%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -56.11M | -104.69M | -119.54M | -147.07M | -151.58M |
| Total Depreciation and Amortization | 8.55M | 8.69M | 8.75M | 8.77M | 7.87M |
| Total Amortization of Deferred Charges | 2.26M | 2.20M | 2.35M | 2.48M | 2.62M |
| Total Other Non-Cash Items | 110.35M | 121.79M | 109.82M | 122.26M | 119.99M |
| Change in Net Operating Assets | -98.94M | -54.51M | -43.27M | -67.16M | -47.99M |
| Cash from Operations | -33.89M | -26.52M | -41.89M | -80.72M | -69.09M |
| Capital Expenditure | -3.55M | -5.00M | -6.21M | -7.31M | -7.44M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.99M | 871.00K | 3.57M | 76.66M | 105.50M |
| Cash from Investing | -560.00K | -4.13M | -2.63M | 69.35M | 98.06M |
| Total Debt Issued | -- | 387.36M | 387.36M | 387.36M | 387.36M |
| Total Debt Repaid | -97.00K | -408.29M | -408.35M | -408.33M | -408.32M |
| Issuance of Common Stock | 27.24M | 57.52M | 76.56M | 101.65M | 103.21M |
| Repurchase of Common Stock | -22.03M | -22.76M | -22.32M | -21.84M | -17.92M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -1.59M | -1.59M | -2.65M | -2.65M |
| Cash from Financing | 5.12M | 12.23M | 31.66M | 56.19M | 61.68M |
| Foreign Exchange rate Adjustments | -4.03M | -11.04M | 10.89M | 2.99M | 6.31M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -33.36M | -29.45M | -1.98M | 47.81M | 96.96M |